Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Compston, J E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Compston, J E
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Medical Bulletin 48:309-344 (1992)
© 1992 The British Council


other

HRT and osteoporosis

J E Compston

Department of Medicine, University of Cambridge, Addenbrooke's Hospital Cambridge, UK

Abstract

Osteoporosis is characterised by low bone mass, leading to an increased risk of fragility fracture, particularly in the femoral neck, vertebrae and radius. These fractures constitute a major public health problem in the Western world; the estimated annual cost to the health services of hip fracture alone is over £500 million in the United Kingdom. Using population-based data from the USA, Cummings et al.1 have estimated that the lifetime risks of hip, vertebral and Colles' fractures in a 50 year old, white, postmenopausal woman are 16%, 32% and 15% respectively. Of these, vertebral fractures probably cause the most significant morbidity, since they occur at a younger age than hip fractures and may result in pain, deformity and disability for many years until death intervenes from other causes. Hip fractures occur most commonly in the eight and ninth decades of life and have a mortality at six months of around 15%, increased dependency occurring in the majority of survivors.2 Colles' fractures, although not usually associated with long-term morbidity, nevertheless cause considerable inconvenience and require hospital treatment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
M. E. Nuttall, G. B. Stroup, P. W. Fisher, D. P. Nadeau, M. Gowen, and L. J. Suva
Distinct mechanisms of action of selective estrogen receptor modulators in breast and osteoblastic cells
Am J Physiol Cell Physiol, November 1, 2000; 279(5): C1550 - C1557.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M.B. Tiras, V. Noyan, A. Yildiz, M. Yildirim, and S. Daya
Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study
Hum. Reprod., October 1, 2000; 15(10): 2087 - 2092.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. M. Raafat, L. J. Hofseth, S. Li, J. M. Bennett, and S. Z. Haslam
A Mouse Model to Study the Effects of Hormone Replacement Therapy on Normal Mammary Gland during Menopause: Enhanced Proliferative Response to Estrogen in Late Postmenopausal Mice
Endocrinology, June 1, 1999; 140(6): 2570 - 2580.
[Abstract] [Full Text]


Home page
JEMHome page
A. M. Hales, C. G. Chamberlain, C. R. Murphy, and J. W. McAvoy
Estrogen Protects Lenses against Cataract Induced by Transforming Growth Factor-{beta} (TGF{beta})
J. Exp. Med., January 20, 1997; 185(2): 273 - 280.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J E Compston
Fortnightly Review: The therapeutic use of bisphosphonates
BMJ, September 17, 1994; 309(6956): 711 - 715.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.